Investor Type | Firm |
Industries | BioTech • Hardware (& Manufacturing) • IoT (& Wearables) • Life Science |
Investing | Sweden |
Impilo is a private equity investment fund based in Stockholm, Sweden, established in 2016 with a dedicated focus on the healthcare sector. The fund specializes in investment opportunities in the Nordics, looking for companies with strong growth prospects and sound business models. Impilo's investment strategy is grounded on several key pillars, including contributing to a sustainable society by improving health and healthcare services, and aiming for strong growth both organically and through add-on acquisitions. Their work extends across a variety of sub-sectors within healthcare, which includes biotechnology, medical technologies, pharmaceuticals, and specialized services. The team at Impilo applies a hands-on investment approach, where they engage closely with the companies they invest in, offering strategic support, operational expertise, and an extensive network in the healthcare industry to foster growth and value creation. They target mid-sized companies in the Nordic region, particularly focusing on investments where they can acquire a significant influence or full control. Impilo is a local partner with a global network, leveraging a team with substantial experience in healthcare and investing, to guide their portfolio companies towards international expansion and increased competitiveness. As experts in the healthcare space, Impilo endeavors to generate not just financial returns but also contribute to the well-being of patients and healthcare systems as a whole.